Ubrogepant Most Effective in Mild vs Moderate or Severe Headache Pain Intensity
Presenting at AHS 2022, researchers assessed the efficacy of a 1-year treatment period with ubrogepant 50 or 100 mg in patients with migraine attacks with mild and moderate or severe pain.